2008 (7 POSTS)

Jolliet O, Jiang X, Wenger Y, Milbrath MO, Chang C-W, Chen Q, Hong B, Hedgeman E, et al. 2008. Model formats and use of pharmacokinetic modeling for the statistical analysis of blood dioxin concentrations. Organohalogen Compounds 70:102–105.

Thompson CM, Sonawane B, Barton HA, DeWoskin RS, Schlosser P, Lipscomb JC, Chiu W, Krishnan K. 2008. Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J Toxicol Environ Health B 11(7):519–547; doi: 10.1080/10937400701724337. PMID: 18584453.

View Abstract

Jolliet O, Wenger Y, Adriaens P, Chang C-W, Chen Q,…, Jiang X, Knutson K,…, Reichert H, et al. Explaining age dependency using pharmacokinetic modeling in the analysis of blood TCDD concentrations. Dioxin 2008 Conference, Birmingham, England, August 1, 2008.

Hinerman J. Crystallographic and small angle scattering studies of the bacteriophage T4 replication complex. Invited presentation to American Crystallographic Association Annual Meeting, Knoxville, TN, June 2008.

Wheeler MW, Bailer AJ. 2008. Model averaging software for dichotomous dose response risk estimation. J Stat Software 26(5):1-15; doi: 10.18637jss.v026.i05.

View Abstract

DeWoskin RS, Thompson CM. 2008. Renal clearance parameters for PBPK model analysis of early lifestage differences in the disposition of environmental toxicants. Regul Toxicol Pharmacol 51(June):66–86; doi: 10.1016/j.yrtph.2008.02.005. PMID: 18433959.

View Abstract

2007 (3 POSTS)

Wheeler MW, Bailer AJ. 2007. Properties of model‐averaged BMDLs: A study of model averaging in dichotomous response risk estimation. Risk Anal 7(3):659-70; doi: 10.1111/j.1539-6924.2007.0090.x. PMID: 17640214.

View Abstract

Wang X, Hsu M-Y, Steinbacher TE, Monticello TM, Schumacher WA. 2007. Quantification of platelet composition in experimental venous thrombosis by real-time polymerase chain reaction. Thromb Res 119(5):595-600; doi: 10.1016/j.thromres.2006.04.011. PMID: 16797058.

View Abstract

Emond C, Raymer J, Garner E, Diliberto J, Staskal D, Birnbaum LS. A physiologically-based pharmacokinetic model for developmental exposure to PBDE-47 in rodents. Society of Toxicology 46th Annual Meeting, Charlotte, NC, March 2007.

2006 (2 POSTS)

Gallegos Saliner A, Patlewicz G, Worth AP. 2006. Review of Literature-Based Models for Skin and Eye Irritation and Corrosion. EUR 22320 EN.

View Abstract

Paustenbach DJ, Panko JM, Scott PK, Unice KM. Retrospective modeling of potential residential exposure to perfluorooctanoic acid (PFOA) releases from a manufacturing facility. Society of Toxicology 45th Annual Meeting, San Diego, CA, March 2006.

2005 (7 POSTS)

Stokes WS, Chambers W, Bonner M, Allen DG, Tice RR, Choksi NY, et al. In vivo models of ocular injury and recovery: Current and potential biomarkers to support development and validation of predictive in vitro models. Presented at the 5th World Congress on Alternatives and Animal Use in the Life Sciences, Berlin, Germany, August 2005.

Unice KM, Panko JM, Scott PK. Development of exposure assessment models for indoor air exposure to elemental mercury. International Society for Exposure Assessment Conference, 2005.

Panko JM, Unice KM, Brown JL. Comparison of toluene exposures during spray painting using various consumer product exposure models. International Society for Exposure Assessment Conference, 2005.

Bailer AJ, Wheeler MW, Dankovic D, Noble R, Bena J. 2005. Incorporating uncertainty and variability in the assessment of occupational hazards. Int J Risk Assess Manage 5(2-4):344-57; doi: 10.1504/IJRAM.2005.007176.

View Abstract

Choksi NY. Current in vitro models of ocular injury and recovery: Vascular assays. Presented at the ICCVAM/NICEATM/ECVAM Ocular Toxicity Scientific Symposium on Mechanisms of Chemically-Induced Ocular Injury and Recovery, May 2005.

Bailer AJ, Noble RB, Wheeler MW. 2005. Model uncertainty and risk estimation for experimental studies of quantal responses. Risk Anal 25(2):291-9; doi: 10.1111/j.1539-6924.2005.00590.x. PMID: 15876205.

View Abstract

Urban JD, Mailman RB. Characterization of the N27 dopaminergic cell line as a model for elucidating the actions of functionally selective dopaminergic ligands. 35th Annual Neuroscience Meeting, Washington, DC, November 2005.

2004 (1 POST)

Perry CS, Morton E. Lessons learned from creating integrated Excel models to calculate human health screening values. Society for Risk Analysis Annual Meeting, Palm Springs, CA, December 2004.

2003 (1 POST)

Haws L. Combustion risk modeling and assessment. Presented at the Texas Commission on Environmental Quality Workshop on Hazardous Waste Combustion, Austin, TX, May 2003.